REGULATED PRESS RELEASE
News
-
-
REGULATED PRESS RELEASE
Biophytis announces new non-clinical data further supporting its mission to pioneer the restoration of mobility in patients with obesity
Biophytis announces new preclinical study results showing combination of BIO101 and GLP-1 restores muscle strength and mobility in obesity patients. The company aims to pioneer mobility restoration in obese patients -
PRESS RELEASE
DBV Technologies conclut un accord avec la FDA sur les données d'innocuité requises pour la demande de BLA du patch Viaskin® Peanut chez les enfants de 4-7 ans, accélérant ainsi au premier semestre 2026 le dépôt de la demande…
DBV Technologies conclut un accord avec la FDA sur les données d'innocuité du patch Viaskin Peanut, anticipant un dépôt au 1er semestre 2026, et publie ses résultats financiers 2024 -
-
PRESS RELEASE
DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
DBV Technologies secures FDA agreement for Viaskin Peanut Patch BLA submission in 4-7-year-olds, accelerating launch timeline by approximately one year. Unaudited 2024 financial results reported -
-
PRESS RELEASE
AEVIS VICTORIA SA - Swiss Medical Network publishes 2024 results and confirms the strength of its integrated care model
Swiss Medical Network (SMN) reports CHF 812.2 million in gross revenues for 2024, an increase of 5.6% from 2023, and outlines expansion and integrated care model strengths -
PRESS RELEASE
AEVIS VICTORIA SA - Swiss Medical Network publie ses résultats 2024 et confirme la solidité de son modèle de soins intégrés
AEVIS VICTORIA SA - Swiss Medical Network publie ses résultats 2024 confirmant la solidité de son modèle de soins intégrés. Croissance organique et acquisitions stimulent les performances -
PRESS RELEASE
PATRIZIA announces FY 2024 preliminary financial results in line with guidance and proposes an increased dividend of EUR 0.35 per share
PATRIZIA SE announces FY 2024 preliminary financial results meeting guidance and proposes increased dividend of EUR 0.35 per share. Company's strategic reorganization and focus on cost efficiency highlighted -
PRESS RELEASE
Formycon invites to conference call on the results of the financial year 2024 and announces participation in international investor conferences in the 2nd quarter of 2025
Formycon announces conference call for fiscal year 2024 results and participation in investor conferences in Q2 2025
